- Report
- April 2025
- 200 Pages
Global
From €4075EUR$4,490USD£3,435GBP
- Report
- March 2025
- 200 Pages
Global
From €4075EUR$4,490USD£3,435GBP
- Report
- June 2025
- 279 Pages
Global
From €5309EUR$5,850USD£4,476GBP
- Report
- June 2025
- 609 Pages
Global
From €5309EUR$5,850USD£4,476GBP
- Report
- December 2024
- 68 Pages
Global
From €3585EUR$3,950USD£3,022GBP
- Report
- December 2024
- 70 Pages
India
From €3176EUR$3,500USD£2,678GBP
Metabolic disorders are a group of conditions that affect the body's ability to produce or respond to hormones that regulate metabolism. These disorders can affect the body's ability to break down and use carbohydrates, proteins, and fats, as well as its ability to regulate blood sugar levels. Endocrinology is the branch of medicine that deals with the diagnosis and treatment of metabolic disorders. Endocrinologists diagnose and treat a wide range of metabolic disorders, including diabetes, thyroid disorders, and obesity.
Metabolic disorders can have a significant impact on a person's quality of life, and can lead to serious health complications if left untreated. Treatment for metabolic disorders typically involves lifestyle changes, such as diet and exercise, as well as medications and other therapies.
Companies in the metabolic disorder market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. Show Less Read more